Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Gea claims antiplatelet and fibrinolytic compounds

June 7, 1996

PharmaGenics discloses oligonucleotides

June 7, 1996

Thrombin inhibitors claimed by Boehringer Mannheim

May 31, 1996

Tirofiban advances through clinical trials; filing in sight

May 24, 1996

IND filing anticipated for TBC-1269

May 24, 1996

VCAM-1/VLA-4 inhibitors in the Texas Biotechnology pipeline

May 24, 1996

Fibrinogen antagonists claimed by Taisho

May 24, 1996

Mitsui Toatsu reports bicyclic fibrinogen antagonists

May 24, 1996

E. Merck claims oxazolidinone adhesion receptor antagonists

May 24, 1996

NovoSeven Spanish introduction imminent

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...